CPIX Cumberland Pharmaceuticals Inc

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company. It is engaged in the acquisition, development and commercialization of branded prescription products. Its target markets are hospital acute care and gastroenterology.

As of 05/10/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  08/11/2009
Outstanding shares:  14,920,655
Average volume:  29,277
Market cap:   $39,688,942
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    230770109
ISIN:        US2307701092
Sedol:      B23WLP8
Valuation   (See tab for details)
PE ratio:   -11.84
PB ratio:   0.83
PS ratio:   1.06
Return on equity:   -7.11%
Net income %:   -8.92%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy